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The hype created by some brain training games in the United States (U.S.), and their role in improving conditions such as ADHD and Alzheimer's disease, ended up with a federal crackdown in 2016 as the Federal Trade Commission charged Lumo Labs for overselling the effectiveness and benefits of Lumosity game series (1) . Empirical studies began to show evidence that the effects of brain training games may be just placebo; however, some researchers took advantage of the placebo effect as they found out that players' expectation can actually influence cognitive performance (2) . This editorial juxtaposes how a Humphrey fellow from Universiti Pendidikan Sultan Idris (UPSI) explored the impact of games for cognitive function throughout a ten-month Hubert H. Humphrey Fellowship Programme at Pennsylvania State University (PSU) and Yale University, and what professionals in low-and middle-income countries should be mindful of when creating or using games in medical or paramedical contexts (Figure 1 ). Explicit use of games as means of teaching and learning at PSU, a member of the Big Ten Academic Alliance (3), is normally limited to individual professors who hold positive perceptions towards games. However, the PSU does offer a course to all faculty and teaching assistants titled Gamification in Online Teaching and Learning (4) . A problem facing academic researchers who are interested in conducting research and development (R&D) projects is they have to conceal that they are creating "games" as mobile or interactive technologies in order to secure public funds e.g., the National Science Foundation. Such scenarios may occur in other Big Ten Academic Alliance universities, due to the lack of confidence towards the prospect of game studies. This could also be the case in Malaysia, where games are generally perceived as non-serious entertainment (5), and not a top priority for public R&D fund appropriation. Professors in medical schools who are interested in using games for teaching purposes can package them as "electronic textbooks" or "interactive technologies". Medical practitioners in hospitals who are interested to initiate or join game-related projects in the U.S. use the terms "software" or "interactive technologies" rather than games to help secure public research funds.
Undergraduate and postgraduate students are constantly encouraged to make games. According to Dr. James Delattre, Assistant Vice President of Research and Director of the Office of Entrepreneurship and Commercialisation, PSU encourages students to work with faculty and community members to develop games or game-like applications. In particular, the Happy Valley LaunchBox was set up to run entrepreneurship programmes, including the Idea TestLab, the FastTrack Accelerator, and the Global Entrepreneurship Week (GEW). In FY2017/2018, two healthcare startups were established: (a) HemoGO, which aims to reduce the necessity of cancer patients to go to a laboratory for regular blood tests (6); and (b) Pathways AI, which enables patients with Parkinson's disease to track health status and transfer the data to physicians (7). Despite demonstrating convincing features, neither of these startups can commercialise the products before passing the U.S. Food and Drug Administration (FDA) Device Clearance, which is the gold standard for any serious games or game-like apps to be distributed in U.S. Such regulation issues must be taken Passing the FDA clearance means physicians in the U.S. can prescribe games as a treatment, which is essential for patients to get insurance reimbursement (8) . In other words, serious games can generate revenues in the pharmaceutical industry, which was worth more than USD 300 billion in Northern America in 2017 alone (9). According to Ms Stephanie Wong, the Head of Trade from the Malaysia Digital Economy Corporation Inc. based in Silicon Valley, the market of Malaysia is too small in the eyes of American venture capitalists. This suggests that health professionals in Southeast Asia should consider entering the North American market as Association of Southeast Asian Nations (ASEAN) rather than Malaysia alone (Figure 2 ). In addition, working under the umbrella of ASEAN may afford R&D teams to conduct product safety and efficacy tests and trials with participants living in different socio-economic conditions across 12 member countries. Hospital in Stanford pioneered the use of distraction-based virtual reality (VR) therapy in all patient units, specifically to alleviate pain and anxiety among pediatric patients (14) . Since a cardboard VR headset which holds almost any smartphone can cost less than USD5 or RM20 now, the practice of distraction-based VR therapy can be replicated and implemented right away in low-income countries to reduce pain and anxiety.
As the computing technology advances, cybersickness in VR gradually becomes a nonissue (15), which opens up an opportunity to exploit the technology for various pragmatic applications. Within the Yale School of Medicine, the Yale Center for Health and Learning Games houses two labs that investigate serious games: the play2PREVENT Lab and the play4REAL Lab (16) (Figure 4 ). The play4REAL Lab is developing VR apps that simulate realistic scenarios in school, social activities and at home where targeted players normally experience in real life. The play2PREVENT Lab has produced and evaluated a series of games for preventing tobacco use, substance abuse, HIV and sexually transmitted infections young adolescents. Researchers in the play2PREVENT and play4REAL labs collaborate with game consultants and developers around the world, opening up opportunities for medical professionals and serious game developers from Southeast Asia who are well-versed in serious games.
The process of creating a game-from an idea, to a prototype game, to a software as medical device (SaMD) that passes FDA clearance-is no doubt a long and expensive journey (8) . Therefore, medical researchers in low-and middle-income countries should target for class 1 or 2 with the lowest or low risk-level, as opposed to class 3 or 4 with the highest or serious risk-level set by FDA (10), as suggested by Noah Falstein in the 2018 Game Developers Conference (Figure 3) . The success of Akili Interactive Labs in turning NeuroRacer into AKL-T001, a digital health product that passed FDA clearance as a prescription treatment has motivated a lot of serious games partnerships between the medical industry and the game industry (11) . NeuroRacer was originally a video game designed as an intervention for top-down modulation deficits in adults aged between 60 to 85 years (12) . The game research project was led by Dr Adam Gazzaley, an Associate Professor of neurology, physiology and psychiatry, and the founding director of Neuroscape in University of California, San Francisco (13). The translational nature of neuroscience seems to have afforded experts in medical sciences to work with professionals in other fields to produce marketable innovation-a model which can be replicated in developing countries.
Medical practitioners who are not interested in creating their own games or passing any FDA clearance can still use games to treat patients. In particular, the Lucile Packard Children's 
